While our findings contrast with a study demonstrating that targeting c-MYC by shRNA or JQ1 treatment decreases PD-L1 in melanoma and lung cancer cells20,21, our findings are in agreement with another study showing that JQ1 regulation of PD-L1 in lymphoma cells is not mediated by c-MYC15. The gene discussed is CD274; the disease is melanoma.